Formedix has announced the expansion of its development and test teams.
The Formedix platform enables pharmaceutical organizations to store, control, and reuse clinical metadata. Its automated processes and API integration functionality allows the rapid design, build, and submission of compliant clinical studies.
The expansion of the development and test teams will allow Formedix to make extensions to the existing platform, while working on cutting edge functionality for future developments.
"We’re really excited to welcome new talent to our teams. Taking on additional developers and testers will let us really focus on new, innovative functionality, whilst at the same time being able to provide enhancements to the current platform," Greg Blincow, Development Manager, said.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!
"The industry as a whole is moving towards using automated software solutions to maximize efficiency gains. Over the last two years, demand for the Formedix platform has increased significantly. Growing our teams will enable us to keep up with increased demands, and ensure we can deliver top-notch customer service backed by a leading-edge product," Darren Bill, Head of Operations, said.
The Formedix platform is currently being used in a number of COVID-19 clinical trials, and by CDISC to develop standardized forms.